Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
EATONTOWN, N.J., March 18, 2026 (GLOBE NEWSWIRE) -- Climb, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB) announced the...
-
17 Education & Technology Group Inc. to Report Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results on March 24, 2025
-
Approval in Costa Rica for Kinesiology Tape Products
-
HOUSTON, March 18, 2026 (GLOBE NEWSWIRE) -- U.S. Energy Corp. (NASDAQ: USEG) (“U.S. Energy” or the “Company”), an integrated energy company advancing a diversified industrial gas, energy, and carbon...
-
Long-term agreement covers maintenance, repairs and advisory services for up to 64 aeroderivative gas turbines critical to Brazil’s offshore and refinery operationsWork to be delivered from the Baker...
-
– ARV-102 reduced endolysosomal and neuroinflammatory biomarkers implicated in Parkinson’s disease and progressive supranuclear palsy – – ARV-102 was well tolerated across all dose levels following...
-
Aclaris Therapeutics Completes Enrollment in Phase 2 Trial of Bosakitug (ATI-045) in Atopic Dermatitis
-
The 7 mg dose of OV329 demonstrated favorable safety and tolerability profile, reinforcing best-in-category potential for refractory epilepsies; Ovid advancing plans to initiate a Phase 2 trial in...
-
Proceeds expected to support expansion of next-generation GABA-aminotransferase inhibitor, OV329, into tuberous sclerosis complex and infantile spasmsFinancing led by Point72 with participation from...
-
Liberty Blume, has announced the appointment of Ian Larkin as Chief Executive Officer to lead the next phase of the company’s growth.